Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.

• The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for CancerSara Karaki, Claudia Andrieu, Hajer Ziouziou and Palma RocchiAnti-Tumor Lipids – Structure, Functions and Medical ApplicationsAneliya Kostadinova, Tanya Topouzova-Hristova, Albena Momchilova, Rumiana Tzoneva and Martin R. BergerTelomere Repeat Factor 2 (Trf2) is Responsible for the Telomere Attachment to the Nuclear MembraneNadya V. Ilicheva, Olga I. Podgornaya and Alex P. VoroninAlterations in Gene Expression in Depression – Prospects for Personalize Patient TreatmentRossen Donev and Khaled AlawamEvolution and Coevolution of Prc2 Genes in Vertebrates and MammalsXi Liu, Jingwen Yang, Nan Wu, Ruixian Song and Hao ZhuQuartz-Crystal Microbalance (QCM) for Public Health: An Overview of its ApplicationsNicola Luigi Bragazzi, Daniela Amicizia, Donatella Panatto, Daniela Tramalloni, Ivana Valle and Roberto GaspariniPorous Alumina as a Promising Biomaterial for Public HealthNicola Luigi Bragazzi, Roberto Gasparini, Daniela Amicizia, Donatella Panatto and Claudio LarosaHuman Papillomavirus (HPV) Vaccine: State of the Art and Future Perspectives Donatella Panatto, Daniela Amicizia, Nicola Luigi Bragazzi, Emanuela Rizzitelli, Daniela Tramalloni, Ivana Valle and Roberto GaspariniSHOPIN: Semantic Homogeneity Optimization in Protein Interaction NetworksKire Trivodaliev, Slobodan Kalajdziski, Ilinka Ivanoska, Biljana Risteska Stojkoska and Ljupco Kocarev